title: Emerging technologies for point-of-care genetic testing.
abstract: In the coming years, genetic test results will be increasingly used as indicators that influence medical decision making. Novel instrumentation that is able to detect relevant mutations in a point-of-care setting is being developed to facilitate this increase, frequently as a spin-off from recent research in the area of biothreat monitoring. This market review will describe the current generation of instrumentation that is most suitable for use in a point-of-care setting; it will also try to identify some of the technologies that will make-up the next generation of instrumentation currently being prepared for the market.
authors.affiliation: National Centre for Medical Genetics, University College Dublin, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland. mark.dobson@ucd.ie
authors.forename: Mark G
authors.initials: MG
authors.lastname: Dobson
authors.forename: Paul
authors.initials: P
authors.lastname: Galvin
authors.forename: David E
authors.initials: DE
authors.lastname: Barton
mesh_terms: D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D005819:Genetic Markers; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000295:instrumentation / Q000379:methods / Q000639:trends; D020411:Oligonucleotide Array Sequence Analysis / Q000295:instrumentation / Q000379:methods / Q000639:trends; D019095:Point-of-Care Systems / Q000639:trends
chemical_list: D005819:Genetic Markers